Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: initial experience of molecularly targeted therapy

BACKGROUND: Although tenosynovial giant cell tumor (TGCT) is classified as a benign tumor, it may undergo malignant transformation and metastasize in extremely rare occasions. High aberrant expression of CSF1 has been implicated in the development of TGCT and recent studies have shown promising acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakayama, Robert, Jagannathan, Jyothi Priya, Ramaiya, Nikhil, Ferrone, Marco L., Raut, Chandrajit P., Ready, John E., Hornick, Jason L., Wagner, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311045/
https://www.ncbi.nlm.nih.gov/pubmed/30594158
http://dx.doi.org/10.1186/s12885-018-5188-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311045/
https://www.ncbi.nlm.nih.gov/pubmed/30594158
http://dx.doi.org/10.1186/s12885-018-5188-6

Ejemplares similares